Previous Article | Next Article ![]()
Infection and Immunity, August 2001, p. 4906-4915, Vol. 69, No. 8
Laboratoire d'Immunologie
(LAF301)1 and Laboratoire
d'Epidémiologie et d'Ecologie
Parasitaire,2 Institut Pasteur de Tunis,
World Health Organization Collaborating Center for Research and
Training in Immunology and Leishmaniasis, 1002 Tunis-Belvédère, Tunisia
Received 2 October 2000/Returned for modification 21 November
2000/Accepted 14 May 2001
Virulence variability was investigated by analyzing the
experimental pathogenicity of 19 Leishmania major strains
in susceptible BALB/c mice. Twelve strains were isolated from Tunisian
patients with zoonotic cutaneous leishmaniasis; seven strains were
isolated in Syria (n = 1), Saudi Arabia
(n = 2), Jordan (n = 2), or Israel (n = 2). BALB/c mice were injected in the hind footpad
with 2 × 106 amastigotes of the various isolates, and
lesion progression was recorded weekly for 9 weeks. Interleukin-4
(IL-4) and gamma interferon (IFN-
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4906-4915.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Heterogeneity of Wild Leishmania major Isolates in
Experimental Murine Pathogenicity and Specific Immune
Response
) production of lymph node
mononuclear cells activated in vitro with parasite antigens were
evaluated 5 weeks after infection. We show that disease progression
induced by different L. major isolates was largely
heterogeneous although reproducible results were obtained when using
the same isolate. Interestingly, isolates from the Middle East induced
a more severe disease than did the majority of Tunisian isolates.
Strains with the highest virulence tend to generate more IL-4 and less
IFN-
in vitro at week 5 postinfection as well as higher levels of
early IL-4 mRNA in the lymph node draining the inoculation site at
16 h postinfection. These results suggest that L. major isolates from the field may differ in virulence, which
influences the course of the disease induced in mice and the type of
immune response elicited by the infected host.
*
Corresponding author. Mailing address: Laboratoire
d'Immunologie, Institut Pasteur de Tunis, BP: 74, 1002 Tunis-Belvédère, Tunisia. Phone: 216-1 783022. Fax:
216-1 791833. E-mail:
hechmi.louzir{at}pasteur.rns.tn.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»